Tobacco cessation in patients with pulmonary carcinoma

• Conditions: C34.9; F17.2; F17; Bronchus or lung, unspecified; Mental and behavioural disorders due to use of tobacco

• Registration Number: DRKS00026813
• Lead Sponsor: Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Universität Augsburg BKH Augsburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-23
• Study Completion: 2023-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

Patient of the Cancer Center
- Diagnosis of a tumor disease of the lung
- Ability to give consent
- Subject must be able to understand the subject information and to give informed consent in writing and on an individual basis.

Exclusion Criteria

- Patients who are unable to form a natural will and are therefore incapable of giving consent.
- Patients with acute suicidal tendencies

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
patient-relevant soft endpoint: Quality of life (McGill Quality of Life)

Secondary Outcome Measures

Name	Time	Method
Hard endpoint: abstinence (measured via self-report, CO measurements of breath, and urine tests of cotinine levels at group completion)